New data on lecanemab to be presented at CTAD conference

STOCKHOLM, Nov. 18, 2025 /PRNewswire/ — BioArctic AB’s (publ) (Nasdaq Stockholm: BIOA B) partner Eisai will present the latest findings on lecanemab (Leqembi®) at the Clinical Trials on Alzheimer’s Disease (CTAD) conference, being held in San Diego December 1-4. Presentations will include data on long-term treatment and estimated time savings over 10 years, as well… Continue reading New data on lecanemab to be presented at CTAD conference

New data on lecanemab to be presented at CTAD conference

STOCKHOLM, Nov. 18, 2025 /PRNewswire/ — BioArctic AB’s (publ) (Nasdaq Stockholm: BIOA B) partner Eisai will present the latest findings on lecanemab (Leqembi®) at the Clinical Trials on Alzheimer’s Disease (CTAD) conference, being held in San Diego December 1-4. Presentations will include data on long-term treatment and estimated time savings over 10 years, as well… Continue reading New data on lecanemab to be presented at CTAD conference

Pony.ai Announces Gen-4 Autonomous Truck Lineup, Set for Mass Production and Deployment in 2026

BEIJING, Nov. 18, 2025 /PRNewswire/ — Pony.ai, a global leader in autonomous driving technology, today announces its fourth-generation (Gen-4) autonomous truck lineup, jointly developed with manufacturing partners including SANY Truck. The Gen-4 autonomous trucks system will utilize 100% automotive-grade components, reducing the bill-of-materials (BOM) cost per vehicle by approximately 70% compared to the previous generation.… Continue reading Pony.ai Announces Gen-4 Autonomous Truck Lineup, Set for Mass Production and Deployment in 2026

Introducing the All-new, All-electric 2026 Jeep® Recon: Trail Rated Capability, Electrified

AUBURN HILLS, Mich., Nov. 18, 2025 /PRNewswire/ —  Continue Reading The all-new, all-electric, Trail Rated 2026 Jeep® Recon. Built for adventure, the all-new 2026 Jeep® Recon is the only fully electric Trail Rated SUV, delivering rugged capability in a fully electrified form Electrified and trail ready, the Jeep Recon delivers 650 horsepower, 620 lb.-ft. of… Continue reading Introducing the All-new, All-electric 2026 Jeep® Recon: Trail Rated Capability, Electrified

Schneider Electric, AVEVA and ETAP Join Alliance for OpenUSD to Advance Digital Twins and 3D Modeling for Industries

Companies will support software interoperability and advance open standards for industrial simulation, collaborative design and AI infrastructure systems Software portfolios of the three companies aid the creation of digital twins, improving building design, sustainability and equipment optimization across multiple industries, including buildings, grids and AI factories Companies align with NVIDIA’s vision for scalable, simulation-ready (SimReady)… Continue reading Schneider Electric, AVEVA and ETAP Join Alliance for OpenUSD to Advance Digital Twins and 3D Modeling for Industries

NUTEX HEALTH REPORTS JUNE 30, 2025 SECOND QUARTER AND YEAR-TO-DATE FINANCIAL RESULTS

Total revenue of $455.8 million for the first half of 2025  versus $143.5 million for the first half of 2024, an increase of 217.5% Net income attributable to Nutex Health Inc. of $3.5 million for the first half of 2025 versus net loss of $0.7 million for the first half of 2024, an increase of $4.2… Continue reading NUTEX HEALTH REPORTS JUNE 30, 2025 SECOND QUARTER AND YEAR-TO-DATE FINANCIAL RESULTS

PROCOMER fördert das Potenzial Costa Ricas als FDI-Standort bei Gesundheits- und Halbleiterunternehmen in Deutschland

Vom 17. bis 21. November wird das Land an zwei großen internationalen Messen teilnehmen: COMPAMED und MEDICA, und Semicon Europa Die Delegation aus Costa Rica wird Gespräche mit potenziellen Investoren von führenden Unternehmen beider Branchen führen BERLIN, 19. November 2025 /PRNewswire/ — Die Agentur für Handels- und Investitionsförderung Costa Ricas (PROCOMER) wird an zwei internationalen… Continue reading PROCOMER fördert das Potenzial Costa Ricas als FDI-Standort bei Gesundheits- und Halbleiterunternehmen in Deutschland

promeut le potentiel du Costa Rica en tant que destination d’investissement direct étranger auprès des entreprises allemandes des secteurs de la santé et des semi-conducteurs

Du 17 au 21 novembre, le pays participera à deux grandes foires commerciales internationales : COMPAMED and MEDICA et Semicon Europa Une délégation costaricienne rencontrera des investisseurs potentiels issus d’entreprises leaders dans les deux secteurs BERLIN, 19 novembre 2025 /PRNewswire/ — L’Agence de promotion du commerce et de l’investissement du Costa Rica (PROCOMER) participera à deux… Continue reading promeut le potentiel du Costa Rica en tant que destination d’investissement direct étranger auprès des entreprises allemandes des secteurs de la santé et des semi-conducteurs

Kessler Topaz Meltzer & Check, LLP Reminds JHX Investors of December 23, 2025 Deadline in Securities Fraud Class Action and Urges Investors with Losses to Contact the Firm

RADNOR, Pa., Nov. 18, 2025 /PRNewswire/ — The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com)  informs investors that a securities class action lawsuit has been filed against James Hardie Industries plc (“James Hardie”) (NYSE: JHX) on behalf of those who purchased or otherwise acquired James Hardie common stock between May 20, 2025, and August… Continue reading Kessler Topaz Meltzer & Check, LLP Reminds JHX Investors of December 23, 2025 Deadline in Securities Fraud Class Action and Urges Investors with Losses to Contact the Firm

NUTEX HEALTH REPORTS RESTATED FIRST QUARTER 2025 FINANCIAL RESULTS

Total revenue of $211.8 million for Q1 2025 versus $67.5 million for Q1 2024, an increase of 214.0% Net income attributable to Nutex Health Inc. of $21.2 million for Q1 2025 versus net loss of $0.4 million for Q1 2024, an increase of $21.6 million. Diluted income per share of $3.33 for Q1 2025 versus… Continue reading NUTEX HEALTH REPORTS RESTATED FIRST QUARTER 2025 FINANCIAL RESULTS